1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | |
| brand | String | Viibryd |
| structure | File | |
| classes | List of String, delimiter: , | Serotonin partial agonist reuptake inhibitor (SPARI) |
| mechanism | String | |
| uses | String | Major depressive disorder in adults (FDA-approved 2011) |
| starting_dose | String | 10 mg PO once daily × 7 days, then 20 mg × 7 days, then 40 mg as target dose (take with food) |
| preparations | String | 10 mg, 20 mg, 40 mg tablets |
| fda_max | String | 40 mg/d |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 4-6 weeks for full antidepressant effect (claimed earlier onset for some patients due to 5HT1A partial agonism) |
| duration | String | Daily dosing |
| halflife | String | ~25 hours |
| bioavailability | String | ~72% (with food); much lower fasting (~36%) |
| pregnancy | String | Limited data; weigh benefits/risks |
| legal | String | Rx |
